Strand Life Sciences bioinformatics company and a subsidiary of Reliance Industries Limited have introduced CancerSpot, a revolutionary blood-based test for the early detection of multiple cancers.
Read More
Over the past ten years, CAPED has reached more than 60.6 million individuals through awareness programs and conducted cancer screenings for over 42,000 women across 573 villages
Read More
The event saw participation from over 70 stakeholders, including government officials, senior clinicians, and representatives from hospitals, MedTech, and pharma companies
Read More
